A Study of SHR-A2009 Versus Platinum-based Chemotherapy in EGFR-mutated, Advanced or Metastatic NSCLC
Clinical trial NCT06671379 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06671379
- Sponsor
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-29
- Primary completion
- 2026-12-01
- Enrollment
- 498
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.